| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/08/2004 | CA2672551A1 Biodegradable block copolymeric compositions for drug delivery |
| 01/08/2004 | CA2492080A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 01/08/2004 | CA2491427A1 Compositions and methods for therapeutic treatment |
| 01/08/2004 | CA2491034A1 Methods and materials for treating human papillomavirus infections |
| 01/08/2004 | CA2490683A1 Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic coating |
| 01/08/2004 | CA2490545A1 Transdermal drug delivery devices having coated microprotrusions |
| 01/08/2004 | CA2490412A1 Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490190A1 Conjugates comprising an nsaid and a sugar and uses thereof |
| 01/08/2004 | CA2490022A1 A platform for transdermal formulations (ptf) |
| 01/08/2004 | CA2489771A1 Biodegradable block copolymeric compositions for drug delivery |
| 01/08/2004 | CA2489688A1 Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton |
| 01/08/2004 | CA2489555A1 Camptothecin-carboxylate formulations |
| 01/08/2004 | CA2489295A1 Spherical pellet containing a water-soluble active ingredient |
| 01/08/2004 | CA2488526A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | CA2487712A1 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 01/08/2004 | CA2486531A1 Compositions and method for enhanced mucosal delivery of interferon beta |
| 01/08/2004 | CA2482161A1 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 01/07/2004 | EP1378525A2 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/07/2004 | EP1378237A1 Remedial agent for chronic articular rheumatism |
| 01/07/2004 | EP1378177A1 Vitamin-containing system for stabilising the immune response of animals |
| 01/07/2004 | EP1377680A2 Diagnosis and treatment of cancer: i |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377571A1 Compounds for use in the treatment of skin conditions |
| 01/07/2004 | EP1377545A1 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae |
| 01/07/2004 | EP1377321A2 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 01/07/2004 | EP1377320A2 Polynucleotide binding complexes comprising sterols and saponins |
| 01/07/2004 | EP1377319A2 Fusion proteins |
| 01/07/2004 | EP1377318A2 Pregabalin lactose conjugates |
| 01/07/2004 | EP1377317A2 Multiple epitopes connected by a carrier |
| 01/07/2004 | EP1377316A1 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 01/07/2004 | EP1377315A2 Pharmaceutical compositions |
| 01/07/2004 | EP1377306A1 Serum albumin binding moieties |
| 01/07/2004 | EP1377302A1 Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues |
| 01/07/2004 | EP1377297A2 Degradation-resistant glucocorticosteroid formulations |
| 01/07/2004 | EP1377284A1 Controlled release arginine formulations |
| 01/07/2004 | EP1377280A2 Bulking agents as satiety agents |
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1377274A2 Drug delivery system for hydrophobic drugs |
| 01/07/2004 | EP1377273A2 Method for producing an active ingredient concentrate, and an active ingredient concentrate |
| 01/07/2004 | EP1377227A1 Vessel sealing instrument |
| 01/07/2004 | EP1377220A1 Fluorescent cobalamins and uses thereof |
| 01/07/2004 | EP1377183A1 Cactaceae-based formulation having the property of fixing fats, and method for obtaining same |
| 01/07/2004 | EP1377180A1 Microcapsules |
| 01/07/2004 | EP1221841B1 Encapsulated active material immobilized in hydrogel microbeads |
| 01/07/2004 | EP1082119B1 Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 01/07/2004 | EP1067907B1 Ocular irrigating solution |
| 01/07/2004 | EP1033988B1 Parenteral formulations comprising 10-hydroxy-10,11-tetrahydrocarbamazepine, water and glucose |
| 01/07/2004 | EP0973505B1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/07/2004 | EP0969846B1 Compositions and methods for reducing ocular hypertension |
| 01/07/2004 | EP0941071B1 Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
| 01/07/2004 | EP0928301B1 Fluid composition for physiological separations |
| 01/07/2004 | EP0917457B1 Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs |
| 01/07/2004 | EP0857081B1 Preparation of peptide containing biodegradable microspheres by melt process |
| 01/07/2004 | EP0785775B1 Melt-extruded orally administrable opioid formulations |
| 01/07/2004 | EP0724436B1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 01/07/2004 | EP0661992B1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 01/07/2004 | CN1466599A 聚合物水分散体 Aqueous polymer dispersion |
| 01/07/2004 | CN1466594A Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/07/2004 | CN1466467A Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2004 | CN1466463A Remedies for ischemic diseases |
| 01/07/2004 | CN1466458A Use of arginine in the preparation of a medicament for the prevention and treatment of the side effcts associated with the intravenous administration |
| 01/07/2004 | CN1466457A Infusion of ciprofloxacin having reduced acid content and being stable in storage |
| 01/07/2004 | CN1466455A Fentanyl composition for nasal administration |
| 01/07/2004 | CN1466452A Composition for the transdermal delivery of fentanyl |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1466450A Dry-powder film coating composition and method of preparation |
| 01/07/2004 | CN1466445A Ultrasonic method and device for wound treatment |
| 01/07/2004 | CN1133466C Gelling ophthalmic composition containing xanthan gum |
| 01/07/2004 | CN1133465C Absorption enhancers for topical pharmaceutical formulations |
| 01/07/2004 | CN1133464C Pharmaceutical compositions for controlled release of soluble receptors |
| 01/07/2004 | CN1133462C Methods and compositions for healing and repair of connective tissue attachment |
| 01/07/2004 | CN1133460C Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroyfatty acid |
| 01/07/2004 | CN1133432C Aqueous liquid preparations |
| 01/07/2004 | CN1133428C Antibacterial composition for topical administration containing antibiotics |
| 01/07/2004 | CN1133427C Solid oral dosage forms of valsartan |
| 01/07/2004 | CN1133426C Novel stable preparation use paracetamol as base and method for preparing same |
| 01/07/2004 | CN1133413C Alpha-hydroxy fatty acid derivatives and cosmetic used composition for external use containing same |
| 01/06/2004 | US6673905 For covalently linking carbohydrates and proteins under neutral conditions, by attaching double bonds to a carrier protein, and attaching a conjugated diene to a carbohydrate hapten, then coupling; vaccines |
| 01/06/2004 | US6673891 For coating medical equipment |
| 01/06/2004 | US6673861 Inverse latices self-invertible with respect to white mineral oils, squalane, hydrogenated polyisobutene, isohexadecane or isododecane and cosmetic, democosmetic, dermopharmaceutical or pharmaceutical compositions comprising them |
| 01/06/2004 | US6673844 Reducing skin sensitivity |
| 01/06/2004 | US6673842 Method of treating onychomycosis |
| 01/06/2004 | US6673838 Succinate salt of O-desmethyl-venlafaxine |
| 01/06/2004 | US6673826 Treating a skin condition or disease characterized by ulceration, inflammation, or blistering of the skin comprising applying to the skin an oil in water emulsion containing allantoin, an anionic emulsifier and beeswax |
| 01/06/2004 | US6673808 Pharmaceutical consisting of tacrolimus tricyclic compound, diethyl sebacate dissolution/absorption promoter, hydrophilic glycol pharmaceutical base, diethylene glycol monoethyl ether compatibilizer and cellulose or carboxyvinyl polymer thickener |
| 01/06/2004 | US6673805 Platinum derivative pharmaceutical formulations |
| 01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 01/06/2004 | US6673767 Gel composition and methods |
| 01/06/2004 | US6673574 Oral delivery of peptides using enzyme-cleavable membrane translocators |
| 01/06/2004 | US6673382 Containing sugar to provide freezing and thawing stability; foods, drinks; treatment of anemia |
| 01/06/2004 | US6673379 Use of non-alkalized cocoa solids in a drink |
| 01/06/2004 | US6673377 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 01/06/2004 | US6673373 Antifungal formulation and the methods for manufacturing and using the same |
| 01/06/2004 | US6673370 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 01/06/2004 | US6673365 Administering hooc-ch2-(r)-cgl-aze-pab where cgl is cyclohexylglycine, aze is azetidine-2-carboxylic acid, and pab is 1-amidino-4-aminomethylbenzene |
| 01/06/2004 | US6673363 Transdermal and topical administration of local anesthetic agents using basic enhancers |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673347 Conjugated to polymer via schiff base, hydrazone, oxime, or azomethine compound; diagnosing tumors and metastasis |
| 01/06/2004 | US6673337 Compositions containing alpha-2-adrenergic agonist components |